Therapies for polycystic kidney disease

Area of Science:

• Nephrology
• Genetics
• Cell Biology

Background:

• Polycystic kidney diseases manifest as tubular or saccular cysts, either connected to or isolated from the renal tubule.
• These diverse genetic conditions share fundamental mechanisms in cystogenesis, formation, and enlargement.
• The primary cilium, a cellular organelle, plays a crucial role in the pathogenesis of inherited renal cystic diseases.

Purpose of the Study:

• To review current and developing therapeutic strategies for inherited renal cystic diseases.
• To highlight therapeutic approaches applicable across various polycystic kidney conditions due to shared pathomechanisms.
• To focus on treatments targeting the common cellular and molecular pathways involved.

Main Methods:

• Review of recent clinical trials and preclinical experiments.
• Analysis of common signaling pathways implicated in cyst development.
• Synthesis of existing and emerging therapeutic interventions.

Main Results:

• Advances in research have identified common signaling pathway involvement in polycystic kidney diseases.
• Preclinical and clinical data support targeted therapies for shared mechanisms.
• Preventive measures include avoiding nephrotoxic agents and maintaining a normal Body Mass Index (BMI).

Conclusions:

• Dietary modifications such as limiting calories, salt, and protein, alongside increased intake of fruits, vegetables, and water, are recommended early.
• Pharmacological treatments targeting cyst initiation and progression are anticipated.
• Management strategies should address both preventive measures and potential future drug therapies.